FGAM
HRTX icon

Financial Gravity Asset Management’s Heron Therapeutics HRTX Stock Holding History

Financial Gravity Asset Management’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-66
Closed -$2K – 1421
2019
Q1 		$2K Buy
+66
New +$1.73K ﹤0.01% 949

Other funds holding HRTX

Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Financial Gravity Asset Management's HRTX Position: Q2 2019 in Review

Financial Gravity Asset Management sold out of Heron Therapeutics (HRTX) in Q2 2019, closing a stake of 66 shares — an estimated $2K sold.

Financial Gravity Asset Management first reported a position in HRTX in Q1 2019 and held it in 1 quarter. The position peaked at $2K in Q1 2019. 176 funds tracked by Wall St. Rank hold HRTX as of Q2 2019.

  • Financial Gravity Asset Management reported no remaining Heron Therapeutics position as of Q2 2019 after selling out during the quarter.
  • Financial Gravity Asset Management sold 66 Heron Therapeutics shares in Q2 2019, an estimated $2K.
  • Financial Gravity Asset Management first reported a position in Heron Therapeutics in Q1 2019 and held it in 1 quarter.
  • Financial Gravity Asset Management's Heron Therapeutics position peaked at $2K in Q1 2019.
  • 176 funds tracked by Wall St. Rank held Heron Therapeutics as of Q2 2019.

Based on Financial Gravity Asset Management's 13F filing for Q2 2019, filed 26 Jul 2019.